Virtu Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Virtu Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-64,839	Closed	-$6.22M	–	2042
2018 Q3	$6.22M	Buy	64,839 +55,293	+579%	+$5.36M	0.38%	34
2018 Q2	$909K	Sell	9,546 -357,483	-97%	-$32.9M	0.05%	449
2018 Q1	$32.2M	Buy	367,029 +354,879	+2,921%	+$32.4M	1.73%	2
2017 Q4	$1.03M	Buy	12,150 +4,997	+70%	+$419K	0.05%	426
2017 Q3	$619K	Buy	+7,153	New	+$573K	0.03%	753
2017 Q1	–	Sell	-560,658	Closed	-$33.2M	–	598
2016 Q4	$33.2M	Buy	560,658 +549,668	+5,002%	+$33.9M	3.53%	3
2016 Q3	$729K	Buy	+10,990	New	+$680K	0.13%	148
2015 Q4	–	Sell	-123,382	Closed	-$7.68M	–	459
2015 Q3	$7.68M	Buy	123,382 +92,527	+300%	+$7.29M	1%	23
2015 Q2	$2.59M	Buy	30,855 +23,358	+312%	+$1.82M	0.23%	81
2015 Q1	$564K	Sell	7,497 -78,810	-91%	-$5.51M	0.06%	176
2014 Q4	$5.37M	Buy	86,307 +65,253	+310%	+$3.72M	0.66%	38
2014 Q3	$1.09M	Sell	21,054 -42,699	-67%	-$2.18M	0.12%	113
2014 Q2	$3.27M	Buy	+63,753	New	+$2.87M	0.43%	56

Other funds holding XBI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Virtu Financial's XBI Position: Q4 2018 in Review

Virtu Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 64,839 shares — an estimated $6.22M sold.

Virtu Financial first reported a position in XBI in Q2 2014 and held it in 13 quarters. The position peaked at $33.2M in Q4 2016. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

Virtu Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
Virtu Financial sold 64,839 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $6.22M.
Virtu Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and held it in 13 quarters.
Virtu Financial's State Street SPDR S&P Biotech ETF position peaked at $33.2M in Q4 2016.
427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.